Preimplantation factor (PIF) predicts subsequent pregnancy loss

Area of Science:

• Reproductive immunology
• Clinical biochemistry

Background:

• Spontaneous abortion is a common complication of early pregnancy.
• Predictive markers for spontaneous abortion are crucial for timely intervention.
• Preimplantation factor (PIF) is a potential biomarker in early pregnancy.

Purpose of the Study:

• To evaluate the predictive ability of preimplantation factor (PIF) for spontaneous abortion.
• To assess PIF levels using the lymphocyte/platelet binding assay (LPBA) in women experiencing pregnancy loss.

Main Methods:

• Serum samples from 57 women with first-trimester pregnancy losses were analyzed using LPBA.
• LPBA involves heat-inactivated sera, donor lymphocytes and platelets, complement, and anti-CD2 antibody.
• Abortus karyotype analysis was performed, and PIF results were compared between normal and abnormal karyotypes.

Main Results:

• PIF assay was negative in all 57 women at the time of abortion.
• Only 8% of women with karyotypically normal abortuses had an initial positive PIF.
• PIF assay became negative at least two weeks before intrauterine demise, despite elevated hCG levels.

Conclusions:

• Measurement of PIF during the first trimester can predict subsequent pregnancy loss.
• The LPBA assay for PIF shows potential as a predictive tool for spontaneous abortion.
• Changes in PIF levels may precede clinical or biochemical evidence of pregnancy failure.